| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IDYA | IDEAYA Biosciences, Inc. | CANAAN X L.P. | 10% Owner | May 28, 2019 | Buy | $10.00 | 400,000 | 4,000,000 | 2,660,713 | May 28, 2019, 04:55 PM | |
| NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | May 13, 2019 | Buy | $15.00 | 50,000 | 750,000 | 2,254,442 | May 13, 2019, 07:32 PM | |
| ITRM | Iterum Therapeutics plc | CANAAN X L.P. | Director | May 30, 2018 | Buy | $13.00 | 506,656 | 6,586,528 | 1,733,170 | May 30, 2018, 05:25 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | May 17, 2018 | Sale | $6.09 | 38,968 | 237,358 | 2,116,552 | May 21, 2018, 04:34 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | May 16, 2018 | Sale | $6.46 | 29,441 | 190,071 | 2,155,520 | May 16, 2018, 05:16 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | May 14, 2018 | Sale | $6.37 | 77,591 | 494,224 | 2,242,676 | May 16, 2018, 05:16 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | May 15, 2018 | Sale | $6.48 | 57,715 | 374,080 | 2,184,961 | May 16, 2018, 05:16 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 23, 2018 | Sale | $20.71 | 59,950 | 1,241,325 | 2,320,267 | Mar 26, 2018, 04:25 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 21, 2018 | Sale | $20.61 | 17,699 | 364,727 | 2,384,976 | Mar 22, 2018, 05:33 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 22, 2018 | Sale | $20.62 | 4,759 | 98,133 | 2,380,217 | Mar 22, 2018, 05:33 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 20, 2018 | Sale | $20.61 | 17,060 | 351,538 | 2,402,675 | Mar 22, 2018, 05:33 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 16, 2018 | Sale | $20.51 | 6,926 | 142,063 | 2,433,174 | Mar 19, 2018, 05:22 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 19, 2018 | Sale | $20.57 | 13,439 | 276,446 | 2,419,735 | Mar 19, 2018, 05:22 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 14, 2018 | Sale | $20.77 | 200 | 4,154 | 2,451,851 | Mar 15, 2018, 04:55 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 15, 2018 | Sale | $20.64 | 11,751 | 242,521 | 2,440,100 | Mar 15, 2018, 04:55 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% Owner | Mar 13, 2018 | Sale | $20.84 | 1,204 | 25,094 | 2,452,051 | Mar 15, 2018, 04:55 PM | |
| PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | Director | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,453,255 | Aug 16, 2016, 06:28 PM |
Menu